(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.35%) $91.45
3.17% $ 0.0960
Live Chart Being Loaded With Signals
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders...
Stats | |
---|---|
Volumen de hoy | 231 126 |
Volumen promedio | 132 918 |
Capitalización de mercado | 6.50M |
EPS | $0 ( 2024-04-04 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-16 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0980 |
ATR14 | $0.00400 (4.17%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-01-03 | Khanna Ashish | Buy | 375 000 | Stock Option (Right to Buy) |
2023-01-03 | Riedel Norbert G | Buy | 420 000 | Stock Option (Right to Buy) |
2023-01-03 | Kidd Andrew | Buy | 700 000 | Stock Option (Right to Buy) |
2022-05-26 | Koppel Adam | Buy | 40 000 | Stock Option (Right to Buy) |
2022-05-26 | Koppel Adam | Buy | 40 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 97 transactions |
Buy: 16 590 862 | Sell: 1 518 818 |
Volumen Correlación
Aptinyx Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
GNUS | 0.981 |
UEIC | 0.973 |
GMBL | 0.966 |
QNRX | 0.946 |
FAMI | 0.945 |
BAND | 0.945 |
JAGX | 0.943 |
INFI | 0.942 |
PIXY | 0.94 |
GROM | 0.938 |
10 Correlaciones Más Negativas | |
---|---|
AGFS | -0.94 |
APEN | -0.935 |
LMRK | -0.889 |
SGEN | -0.885 |
KNBE | -0.884 |
TIG | -0.883 |
MYRG | -0.876 |
RDUS | -0.875 |
QADA | -0.871 |
IMRA | -0.862 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Aptinyx Inc Correlación - Moneda/Commodity
Aptinyx Inc Finanzas
Annual | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-0.950 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $0 (0.00 %) |
EPS: | $-0.950 |
FY | 2021 |
Ingresos: | $1.00M |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $0 |
FY | 2020 |
Ingresos: | $1.56M |
Beneficio Bruto: | $1 564.00 (0.10 %) |
EPS: | $-1.020 |
Financial Reports:
No articles found.
Aptinyx Inc
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as in Phase II/b clinical trial for treating fibromyalgia. It is also developing NYX-783, an N-methyl-D-aspartate receptors (NMDAr) modulator that is in Phase II/b clinical trial to treat post-traumatic stress disorder; and NYX-458, an NMDAr modulator, which is in Phase II clinical study for the treatment of Parkinson's disease cognitive impairment. The company has a research collaboration agreement with Allergan plc. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico